Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma

Yuan‐Zheng Xia(China Pharmaceutical University), Ling‐Yi Kong(China Pharmaceutical University)
Oncotarget
July 28, 2016
Cited by 22


Related Papers